Literature DB >> 26647209

Open Treatment of Blunt Injuries of Supra-Aortic Branches: Case Series.

Milos Sladojevic1, Miroslav Markovic2, Nikola Ilic2, Sinisa Pejkic2, Igor Banzic2, Predrag Djoric2, Igor Koncar2, Ivan Tomic3, Lazar Davidovic2.   

Abstract

BACKGROUND: Blunt injuries of the supra-aortic branches are rare entity, and majority of patients die before arrival at the hospital. Those who arrive alive require complex and fast procedure that requires sternotomy. We report 3 successfully managed cases. CASE REPORTS: We report 3 patients with injury of supra-aortic branches. One was treated urgently due to longitudinal rupture on the posterior wall of innominate artery after car accident, and another 2 had chronic false aneurysm located at the very orifice of the right subclavian and left common carotid artery. In first and second patient bypass grafting with a hand-made, Y-shaped, 8-mm Dacron graft from the ascending aorta to the right common carotid and proximal right subclavian artery were performed, whereas in last 1 bypass grafting from the ascending aorta to the cervical part of the left common carotid artery was performed. In our facility, there were no possibilities for any endovascular treatment.
CONCLUSIONS: When endovascular technology is not available, open surgical repair of blunt injuries of supra-aortic vessels can be performed without complications. No matter to that, endovascular and hybrid procedures should be considered whenever possible.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26647209     DOI: 10.1016/j.avsg.2015.07.049

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  1 in total

1.  Endovascular repair of an innominate artery pseudoaneurysm using the Valiant Mona LSA branched graft device.

Authors:  Josh A Sibille; Joel P Harding; Jocelyn K Ballast; Mohammad Hooshmand; Jeko M Madjarov; Frank R Arko
Journal:  J Vasc Surg Cases Innov Tech       Date:  2016-12-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.